Simulations Plus Inc
SLP14.570USD
+0.430+3.04%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
293.54MValor de mercado
PerdaP/L TTM
Mais detalhes de Simulations Plus Inc Empresa
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Informações de Simulations Plus Inc
Código da empresaSLP
Nome da EmpresaSimulations Plus Inc
Data de listagemJun 18, 1997
CEOO'Connor (Shawn M)
Número de funcionários212
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço800 Park Offices Drive, Suite 401
CidadeRESEARCH TRIANGLE PARK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Telefone16617237723
Sitehttps://www.simulations-plus.com/
Código da empresaSLP
Data de listagemJun 18, 1997
CEOO'Connor (Shawn M)
Executivos da empresa Simulations Plus Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.28M
+1776.00%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+8950.00%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
15.06K
+1776.00%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
12.47K
+1776.00%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Lisa Lavange
Dr. Lisa Lavange
Independent Director
Independent Director
--
--
Mr. William (Will) Frederick
Mr. William (Will) Frederick
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Jonathan Chauvin
Dr. Jonathan Chauvin
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.28M
+1776.00%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+8950.00%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
15.06K
+1776.00%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
12.47K
+1776.00%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Software licenses
45.83M
57.88%
Consulting services
33.35M
42.12%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
57.70M
72.87%
Europe
14.19M
17.92%
Asia
7.29M
9.20%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Software licenses
45.83M
57.88%
Consulting services
33.35M
42.12%
Distribuição de ações
Atualizado em: qui, 5 de fev
Atualizado em: qui, 5 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
5.02%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
Outro
65.47%
Investidores
Investidores
Proporção
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
5.02%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
Outro
65.47%
Tipos de investidores
Investidores
Proporção
Investment Advisor
36.70%
Investment Advisor/Hedge Fund
22.17%
Individual Investor
17.33%
Hedge Fund
10.72%
Research Firm
8.85%
Pension Fund
0.49%
Bank and Trust
0.21%
Venture Capital
0.11%
Insurance Company
0.03%
Outro
3.38%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
414
15.79M
78.38%
-4.13M
2025Q3
399
15.45M
76.77%
-3.13M
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Woltosz (Walter S)
3.28M
16.28%
-9.10K
-0.28%
Dec 18, 2025
BlackRock Institutional Trust Company, N.A.
1.06M
5.29%
-1.18M
-52.66%
Sep 30, 2025
The Vanguard Group, Inc.
974.48K
4.84%
-197.15K
-16.83%
Sep 30, 2025
Morgan Stanley & Co. LLC
832.51K
4.13%
+582.97K
+233.61%
Sep 30, 2025
First Light Asset Management, LLC
767.76K
3.81%
+410.60K
+114.96%
Sep 30, 2025
Rockefeller Capital Management
745.96K
3.7%
+366.80K
+96.74%
Sep 30, 2025
Columbia Threadneedle Investments (UK)
602.47K
2.99%
+884.00
+0.15%
Sep 30, 2025
Tributary Capital Management, LLC
568.49K
2.82%
+207.21K
+57.36%
Sep 30, 2025
Stephens Investment Management Group, LLC
392.84K
1.95%
+124.26K
+46.27%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
410.85K
2.04%
-74.55K
-15.36%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
State Street SPDR FactSet Innovative Technolgy ETF
0.58%
Global X HealthTech ETF
0.31%
First Trust Active Factor Small Cap ETF
0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
0.21%
Franklin Exponential Data ETF
0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.09%
Principal U.S. Small-Cap ETF
0.07%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
Ver Mais
State Street SPDR FactSet Innovative Technolgy ETF
Proporção0.58%
Global X HealthTech ETF
Proporção0.31%
First Trust Active Factor Small Cap ETF
Proporção0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporção0.21%
Franklin Exponential Data ETF
Proporção0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporção0.09%
Principal U.S. Small-Cap ETF
Proporção0.07%
iShares Micro-Cap ETF
Proporção0.06%
iShares Russell 2000 Growth ETF
Proporção0.02%
Proshares Ultra Russell 2000
Proporção0.01%
Dividendo
Um total de
19.26M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
